Loading clinical trials...
Loading clinical trials...
A Phase 1, Study to Evaluate the Pharmacokinetics and Safety of Zuranolone in Adolescents (12 to 17 Years of Age) With Major Depressive Disorder
Conditions
Interventions
Zuranolone
Locations
4
United States
Sage Investigational Site
Atlanta, Georgia, United States
Sage Investigational Site
Decatur, Georgia, United States
Sage Investigational Site
Flowood, Mississippi, United States
Sage Investigational Site
Cincinnati, Ohio, United States
Start Date
April 19, 2023
Primary Completion Date
October 18, 2024
Completion Date
October 18, 2024
Last Updated
March 26, 2025
NCT07523048
NCT07226661
NCT07115329
NCT06793397
NCT07025720
NCT06132581
Lead Sponsor
Biogen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions